Friday 5 December 2014

Pharmacoepidemiology and Pharmacovigilance

Introduction
Pharmacoepidemiology is the “study of the use of and the effects of drugs in large numbers of people”. It borrows heavily from methods used in general epidemiology.  Areas of focus in pharmoepidemiology are: costs of medicines; patterns and determinant s of consumption; quality of drug use and dispensing; effectiveness of   drugs; drug related policies; formulation of treatment guidelines; and drug supply problems. 
Pharmacovigilance is also known as Drug Safety and is a pharmacological science.  Its main focus is the collection, detection, assessment, monitoring, and prevention of adverse effects and medication errors caused by pharmaceuticals and medical deveices. The word Pharmacovigilance is derived from the Greek and Latin words pharmakon and vigilare which mean “drug” and “to watch out respectively”. The prevalent of drug induced adverse effects is very high.  Medication errors such as overdose, misuse and abuse are common. Pharmacovigilance is considered to be a branch of Pharmacoepidemiology.
In Kenya, pharmacovigilance activities were initiated and co-ordinated by the Pharmacy and Poisons Board which is a World Health Organisation/Uppsala Monitoring regional  center for pharmacovigilance. Online reporting of mediation errors and adverse drug reactions can be done at www.pv.pharmacyboardkenya.org.
History of the Thematic Unit
The development of a postgraduate training curriculum in Pharmacoepidemiology and Pharmacovigilance began in 2005 in response to a need for specialists in this area.  Development of the curriculum was supported by Management Sciences for Health.  The Department of Pharmacology and Pharmacognosy received senate approval in December, 2011 to offer the program. The first lot of 11 students was received in September, 2012.
Programs/courses offered
The thematic unit offers training at post-graduate level to students pursuing Master of Pharmacy in Pharmacoepidemiology and Pharmacovigilance.  Under the unit/module  Pharmacovigilance learners on trained on:
  • How to code adverse drug events
  • Methods and tools for reporting
  • Seriousness and causality assessment
  • Reporting methods
  • Regulations on reporting
  • Managing an adverse event
Pre-requisites for training in Pharmacoepidemiology and Pharmacovigilance are: undergraduate training in pharmacology.  Foundation courses in the post-graduate program are:  epidemiological methods, biostatistics and research methodology. Other modules/units offered include pharmacoeconomics,  regulatory pharmacovigilance, drug utilization review/studies; evidence based health care  and an introductory course on pharmacogenetics.
In addition, the thematic unit offers post-graduate training in Epidemiology to students pursuing a Master of Pharmacy  in Clinical Pharmacy.  It also offers post-graduate training in Research Methods to all post-graduate students registered in the School of Pharmacy.
Research and Projects / Impact of the Thematic Unit
Though the program is still in its infancy, Kenyatta National Hospital has benefitted from the services provided by the learners.  Five drug utilization studies have already been carried out and problems identified in drug use were presented to the Medicines and Therapeutics Committee of the Hospital.  It is hope that these studies will be used to modify current practice.
In this year, the learners submitted 33 reports on adverse drug reactions to the Pharmacy and Poisons Board Pharmacovigilance unit.
Members of unit have supervised about 15 students pursuing post graduate studies in Master of Pharmacy (Clinical Pharmacy).  About 5 papers have resulted from the supervised research activities. 
One comparative study on the renotoxicity of  stavudine and tenofovir was presented at the International Society of Pharmacoepidemiology annual  conference in Barcelona, 2012.  A second study that examined patterns of antibiotic use in patients with renal failure will be presented in an ISPE conference in Canada in 2013. 
Future plans
The unit hopes to work with the Pharmacovigilance Unit of the Board and other stakeholders to strengthen drug regulation in Kenya.  It also hopes to work together with the Department of Quality Assurance of the Ministry of Health in treatment guideline development and monitoring quality of care.
Career opportunities
All alumni of the Pharmacology and Therapeutics thematic unit can pursue careers in academia, clinical trials, health programs (e.g. BASCOP), regulatory institutions (e.g. Pharmacy and Poisons Board), hospitals and health facilitites and institutions involved in drug research.

1 comment: